Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S23 pseudogene 3 (RPS23P3)
- Target
- RPS23P3
- Molecular classification
- Other (Processed pseudogene; not a receptor, enzyme, transporter, transcription factor, etc.)
01
Overview
Ribosomal protein S23 pseudogene 3 (RPS23P3) is a genomic sequence in humans classified as a processed pseudogene of the RPS23 gene, which encodes a protein component of the small 40S subunit of the ribosome. Like other processed pseudogenes of ribosomal protein genes, RPS23P3 does not produce a functional protein product and has no known physiological or pharmacological significance. Multiple pseudogenes exist in the human genome for ribosomal proteins, and they are generally non-functional relics arising from historical duplication or retroposition events. There is no evidence that RPS23P3 has a role in disease, cellular pathways, or drug interactions. RPS23P3 is a non-functional processed pseudogene of the ribosomal protein S23 gene and does not represent a drug target, receptor, or disease-associated molecule in any established database or literature.
- Other names
- RPS23_1_489RPS23P3
02
Mechanism of action
None
03
Biological functions
None (as a pseudogene, RPS23P3 does not have a defined or experimentally characterized biological function)
04
Disease associations
None (no evidence for involvement in any disease processes; contrast with the functional ribosomal protein S23 gene, which is associated with conditions such as autism spectrum disorder and brachycephaly, but not its pseudogenes)
05
Safety considerations
None reported or relevant, as it is not targeted by drugs and has no known physiological role
Beyond the preview
Go deeper on Ribosomal protein S23 pseudogene 3 (RPS23P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein S23 pseudogene 3 (RPS23P3).